Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice

Stem Cells and Development

Volumn 20, Issue 12, 2011, Pages 2065-2076

  Cristofanilli, Massimiliano ^a   Harris, Violaine K ^a   Zigelbaum, Aaron ^a   Goossens, Andrea M ^a   Lu, Amy ^a   Rosenthal, Hannah ^a   Sadiq, Saud A ^a  

^a Multiple Sclerosis Research Center of New York Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; CD9 ANTIGEN; ENDOGLIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HERMES ANTIGEN; MYELIN BASIC PROTEIN; NERVE CELL ADHESION MOLECULE; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; OLIG 1 PROTEIN; OLIG 2 PROTEIN; PROTEIN; STAGE SPECIFIC EMBRYO ANTIGEN 1; STAGE SPECIFIC EMBRYO ANTIGEN 3; STEM CELL ANTIGEN 1; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CELL ACTIVATION; CELL MATURATION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATING DISEASE; EMBRYO; ENGRAFTMENT; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROGLIA; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROCYTE PROGENITOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; T LYMPHOCYTE;

ANIMALS; BONE MARROW CELLS; BRAIN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; FLOW CYTOMETRY; GLIOSIS; GREEN FLUORESCENT PROTEINS; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MYELIN SHEATH; OLIGODENDROGLIA; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 79957876410     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0547     Document Type: Article

References (55)

1. Noseworthy JH, C Lucchinetti, M Rodriguez and BG Weinshenker2000). Multiple sclerosis. N Engl J Med 343:938-952.
2. Gironi M, A Bergami, E Brambilla, F Ruffini, R Furlan, G Comi and G Martino2000). Immunological markers in multiple sclerosis. Neurol Sci 21:S871-S875.
3. Hemmer B, S Cepok, S Nessler and N Sommer2002). Pathogenesis of multiple sclerosis: an update on immunology. Curr Opin Neurol 15:227-231.
4. Lassmann H2002). Mechanisms of demyelination and tissue destruction in multiple sclerosis. Clin Neurol Neurosurg 104:168-171.
5. Franklin RJ2002). Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3:705-714.
6. Kornek B, MK Storch, R Weissert, E Wallstroem, A Stefferl, T Olsson, C Linington, M Schmidbauer and H Lassmann2000). Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157:267-276.
7. Trapp BD, J Peterson, RM Ransohoff, R Rudick, S Mork and L Bo1998). Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285.
8. Ferguson B, MK Matyszak, MM Esiri and VH Perry1997). Axonal damage in acute multiple sclerosis lesions. Brain 120 (Pt 3):393-399.
9. Lovas G, N Szilagyi, K Majtenyi, M Palkovits and S Komoly2000). Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 123 (Pt 2):308-317.
10. Aktas O, B Kieseier and HP Hartung2010). Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis. Trends Neurosci 33:140-152.
11. Pluchino S and G Martino2008). The therapeutic plasticity of neural stem/precursor cells in multiple sclerosis. J Neurol Sci 265:105-110.
12. Pluchino S, L Zanotti, E Brini, S Ferrari and G Martino2009). Regeneration and repair in multiple sclerosis: the role of cell transplantation. Neurosci Lett 456:101-106.
13. Goldman S2005). Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol 23:862-871.
14. Keyoung HM and SA Goldman2007). Glial progenitorbased repair of demyelinating neurological diseases. Neurosurg Clin N Am 18:93-104, x.
15. Tambuyzer BR, I Bergwerf, N De Vocht, K Reekmans, J Daans, PG Jorens, H Goossens, DK Ysebaert, S Chatterjee, E Van Marck, ZN Berneman and P Ponsaerts2009). Allogeneic stromal cell implantation in brain tissue leads to robust microglial activation. Immunol Cell Biol 87:267-273.
16. Wu DC, AS Boyd and KJ Wood2008). Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells 26:1939-1950.
17. Tepavcevic V and WF Blakemore2005). Glial grafting for demyelinating disease. Philos Trans R Soc Lond B Biol Sci 360:1775-1795.
18. Nauta AJ and WE Fibbe2007). Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506.
19. English K, A French and KJ Wood2010). Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell 7:431-442.
20. Privat A, C Jacque, JM Bourre, P Dupouey and N Baumann1979). Absence of the major dense line in myelin of the mutant mouse "shiverer". Neurosci Lett 12:107-112.
21. Roach A, K Boylan, S Horvath, SB Prusiner and LE Hood1983). Characterization of cloned cDNA representing rat myelin basic protein: absence of expression in brain of shiverer mutant mice. Cell 34:799-806.
22. Gumpel M, N Baumann, M Raoul and C Jacque1983). Survival and differentiation of oligodendrocytes from neural tissue transplanted into new-born mouse brain. Neurosci Lett 37:307-311.
23. Gumpel M, O Gout, C Lubetzki, A Gansmuller and N Baumann1989). Myelination and remyelination in the central nervous system by transplanted oligodendrocytes using the shiverer model. Discussion on the remyelinating cell population in adult mammals. Dev Neurosci 11:132-139.
24. Windrem MS, MC Nunes, WK Rashbaum, TH Schwartz, RA Goodman, G McKhann, 2nd, NS Roy and SA Goldman2004). Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 10:93-97.
25. Windrem MS, SJ Schanz, M Guo, GF Tian, V Washco, N Stanwood, M Rasband, NS Roy, M Nedergaard, LA Havton, S Wang and SA Goldman2008). Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell 2:553-565.
26. Okabe M, M Ikawa, K Kominami, T Nakanishi and Y Nishimune1997). ''Green mice'' as a source of ubiquitous green cells. FEBS Lett 407:313-319.
27. Abbondanzo SJ, I Gadi and CL Stewart1993). Derivation of embryonic stem cell lines. Methods Enzymol 225:803-823.
28. Brustle O, KN Jones, RD Learish, K Karram, K Choudhary, OD Wiestler, ID Duncan and RD McKay1999). Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 285:754-756.
29. Groves AK, SC Barnett, RJ Franklin, AJ Crang, M Mayer, WF Blakemore and M Noble1993). Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 362:453-455.
30. Blakemore WF, JM Gilson and AJ Crang2000). Transplanted glial cells migrate over a greater distance and remyelinate demyelinated lesions more rapidly than endogenous remyelinating cells. J Neurosci Res 61:288-294.
31. Warrington AE, E Barbarese and SE Pfeiffer1993). Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. J Neurosci Res 34:1-13.
32. Schulte-Herbruggen O, A Braun, S Rochlitzer, MC Jockers- Scherubl and R Hellweg2007). Neurotrophic factors-a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases? CurrMed Chem14:2318-2329.
33. Zuccato C and E Cattaneo2009). Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5:311-322.
34. Iwata NK and Y Ugawa2005). The effects of cerebellar stimulation on the motor cortical excitability in neurological disorders: a review. Cerebellum 4:218-223.
35. Thickbroom GW2007). Transcranial magnetic stimulation and synaptic plasticity: experimental framework and human models. Exp Brain Res 180:583-593.
36. Steele J, D Zutshi and WG Bradley2007). Negative results of a phase II study of hyperbaric oxygen therapy for amyotrophic lateral sclerosis. Amyotroph Lateral Scler 8:274-275.
37. Dave KR, R Prado, R Busto, AP Raval, WG Bradley, D Torbati and MA Perez-Pinzon2003). Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in Wobbler mice. Neuroscience 120:113-120.
38. Chamberlain G, J Fox, B Ashton and J Middleton2007). Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739-2749.
39. Liu S, Y Qu, TJ Stewart, MJ Howard, S Chakrabortty, TF Holekamp and JW McDonald2000). Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci USA 97:6126-6131.
40. Nistor GI, MO Totoiu, N Haque, MK Carpenter and HS Keirstead2005). Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49:385-396.
41. Uchino H, E Elmer, K Uchino, PA Li, QP He, ML Smith and BK Siesjo1998). Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat. Brain Res 812:216-226.
42. Caplan AI and JE Dennis2006). Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076-1084.
43. Neuhuber B, B Timothy Himes, JS Shumsky, G Gallo and I Fischer2005). Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res 1035: 73-85.
44. Wislet-Gendebien S, F Bruyere, G Hans, P Leprince, G Moonen and B Rogister2004). Nestin-positive mesenchymal stem cells favour the astroglial lineage in neural progenitors and stem cells by releasing active BMP4. BMC Neurosci 5:33.
45. Abboud SL, CR Bethel and DC Aron1991). Secretion of insulin like growth factor I and insulin like growth factorbinding proteins by murine bone marrow stromal cells. J Clin Invest 88:470-475.
46. Bai L, A Caplan, D Lennon and RH Miller2007). Human mesenchymal stem cells signals regulate neural stem cell ate. Neurochem Res 32:353-362.
47. Rivera FJ, S Couillard-Despres, X Pedre, S Ploetz, M Caioni, C Lois, U Bogdahn and L Aigner2006). Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells. Stem Cells 24:2209-2219.
48. Rivera FJ, FA Siebzehnrubl, M Kandasamy, S Couillard- Despres, M Caioni, AM Poehler, B Berninger, B Sandner, U Bogdahn, M Goetz, I Bluemcke, N Weidner and L Aigner2009). Mesenchymal stem cells promote oligodendroglial differentiation in hippocampal slice cultures. Cell Physiol Biochem 24:317-324.
49. Du Y and CF Dreyfus2002). Oligodendrocytes as providers of growth factors. J Neurosci Res 68:647-654.
50. Wilkins A, H Majed, R Layfield, A Compston and S Chandran2003). Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci 23:4967-4974.
51. Zhang YW, J Denham and RS Thies2006). Oligodendrocyte progenitor cells derived from human embryonicstem cells express neurotrophic factors. Stem Cells Dev 15:943-952.
52. Williams A, G Piaton, MS Aigrot, A Belhadi, M Theaudin, F Petermann, JL Thomas, B Zalc and C Lubetzki2007). Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain 130:2554-2565.
53. Rivera FJ, C Steffenhagen, D Kremer, M Kandasamy, B Sandner, S Couillard-Despres, N Weidner, P Kury and L Aigner2010). Deciphering the oligodendrogenic program of neural progenitors: cell intrinsic and extrinsic regulators. Stem Cells Dev 19:595-606.
54. Herrmann MM, S Gaertner, C Stadelmann, J van den Brandt, R Boscke, W Budach, HM Reichardt and R Weissert2005). Tolerance induction by bone marrow transplantation in a multiple sclerosis model. Blood 106:1875-1883.
55. Martino G and S Pluchino2006). The therapeutic potential of neural stem cells. Nat Rev Neurosci 7:395-406.